Colloidal stability of polymeric nanoparticles in biological fluids

Journal of Nanoparticle Research

Volumn 14, Issue 6, 2012, Pages

  Lazzari, Stefano ^a   Moscatelli, Davide ^b   Codari, Fabio ^a   Salmona, Mario ^c   Morbidelli, Massimo ^a   Diomede, Luisa ^c  

^a ETH ZURICH   (Switzerland)

^b POLITECNICO DI MILANO   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Gastrointestinal fluids; Homogenates; Nanomedicine; Nanoparticles; Poly lactic acid; Poly methyl methacrylate; Serum

Indexed keywords

DYNAMIC LIGHT SCATTERING; ESTERS; LACTIC ACID; MEDICAL APPLICATIONS; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; POLYMERS; SOLS;

BIOLOGICAL ENVIRONMENTS; BIOMEDICAL APPLICATIONS; COLLOIDAL STABILITY; HOMOGENATES; PHYSICAL STABILITY; POLY LACTIC ACID; POLYMERIC NANOPARTICLES; SERUM;

STABILITY;

BIOLOGICAL PRODUCT; NANOPARTICLE; POLY(METHYL METHACRYLATE); POLYLACTIC ACID;

ARTICLE; COLLOID; EX VIVO STUDY; IN VIVO STUDY; LIGHT SCATTERING; LIQUID; MEDICAL TECHNOLOGY; NANODEVICE; POLYMERIZATION; PRIORITY JOURNAL; SERUM; SPECTROFLUOROMETRY; SPLEEN; STOMACH JUICE; TISSUE HOMOGENATE;

EID: 84861742973     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-012-0920-7     Document Type: Article

References (28)

1. P Aggarwal JB Hall CB McLeland MA Dobrovolskaia SE McNeil 2009 Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy Adv Drug Deliv Rev 61 6 428 437 10.1016/j.addr.2009.03.009 10.1016/j.addr.2009.03.009 1:CAS:528:DC%2BD1MXmsF2js7w%3D
2. F Alexis E Pridgen LK Molnar OC Farokhzad 2008 Factors affecting the clearance and biodistribution of polymeric nanoparticles Mol Pharm 5 4 505 515 10.1021/mp800051m 10.1021/mp800051m 1:CAS:528:DC%2BD1cXpt1Wlurs%3D
3. DY Arifin LY Lee CH Wang 2006 Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems Adv Drug Deliv Rev 58 12-13 1274 1325 10.1016/j.addr.2006.09.007 10.1016/j.addr.2006.09. 007 1:CAS:528:DC%2BD28Xht1CnsLzO
4. K Avgoustakis A Beletsi Z Panagi P Klepetsanis AG Karydas DS Ithakissios 2002 PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties J Control Release 79 1-3 123 135 10.1016/S0168-3659(01)00530-2 1:CAS:528: DC%2BD38XhtlSlsL4%3D (Pubitemid 34164166)
5. F Codari D Moscatelli G Storti M Morbidelli 2010 Characterization of low-molecular-weight PLA using HPLC Macromol Mater Eng 295 1 58 66 10.1002/mame.200900172 10.1002/mame.200900172 1:CAS:528:DC%2BC3cXosF2mug%3D%3D
6. F Cui F Qian Z Zhao L Yin C Tang C Yin 2009 Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles Biomacromolecules 10 5 1253 1258 10.1021/bm900035u 10.1021/bm900035u 1:CAS:528:DC%2BD1MXjt1Gqtb4%3D
7. H Devalapally A Chakilam MM Amiji 2007 Role of nanotechnology in pharmaceutical product development J Pharm Sci 96 10 2547 2565 10.1002/jps.20875 10.1002/jps.20875 1:CAS:528:DC%2BD2sXhtFKrtLnK (Pubitemid 47603100)
8. H Fessi F Puisieux JP Devissaguet N Ammoury S Benita 1989 Nanocapsule formation by interfacial polymer deposition following solvent displacement Int J Pharm 55 1 R1 R4 10.1016/0378-5173(89)90281-0 1:CAS:528:DyaL1MXmtF2hsbs%3D (Pubitemid 19247505)
9. CB He YP Hu LC Yin C Tang CH Yin 2010 Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles Biomaterials 31 13 3657 3666 10.1016/j.biomaterials.2010.01.065 10.1016/j.biomaterials.2010.01.065 1:CAS:528:DC%2BC3cXisFSltrg%3D
10. M Kuentz 2008 Drug absorption modeling as a tool to define the strategy in clinical formulation development AAPS J 10 3 473 479 10.1208/s12248-008-9054- 3 10.1208/s12248-008-9054-3
11. A Kumari SK Yadav SC Yadav 2010 Biodegradable polymeric nanoparticles based drug delivery systems Colloids Surf B 75 1 1 18 10.1016/j.colsurfb.2009. 09.001 10.1016/j.colsurfb.2009.09.001 1:CAS:528:DC%2BD1MXhsVKntr%2FO
12. D Lemoine C Francois F Kedzierewicz V Preat M Hoffman P Maincent 1996 Stability study of nanoparticles of poly(epsilon-caprolactone), poly(d,l-lactide) and poly(d,l-lactide-co-glycolide) Biomaterials 17 22 2191 2197 10.1016/0142-9612(96)00049-X 1:CAS:528:DyaK28Xmslejur8%3D (Pubitemid 26364773)
13. Y Liu CY Cheng RK Prud'homme RO Fox 2008 Mixing in a multi-inlet vortex mixer (MIVM) for flash nano-precipitation Chem Eng Sci 63 11 2829 2842 10.1016/j.ces.2007.10.020 10.1016/j.ces.2007.10.020 1:CAS:528: DC%2BD1cXlvVOhsrk%3D (Pubitemid 351636094)
14. M Madlova SA Jones I Zwerschke Y Ma RC Hider B Forbes 2009 Poly(vinyl alcohol) nanoparticle stability in biological media and uptake in respiratory epithelial cell layers in vitro Eur J Pharm Biopharm 72 2 437 443 10.1016/j.ejpb.2009.01.009 1:STN:280:DC%2BD1Mzmt1ehtw%3D%3D
15. L Masaro XX Zhu 1999 Physical models of diffusion for polymer solutions, gels and solids Prog Polym Sci 24 5 731 775 10.1016/S0079-6700(99)00016-7 1:CAS:528:DyaK1MXlvFWmurk%3D (Pubitemid 30497914)
16. AM Mohs HW Duan BA Kairdolf AM Smith SM Nie 2009 Proton-resistant quantum dots: stability in gastrointestinal fluids and implications for oral delivery of nanoparticle agents Nano Res 2 6 500 508 10.1007/s12274-009-9046-3 10.1007/s12274-009-9046-3 1:CAS:528:DC%2BD1MXhtFSjsbbJ
17. CE Mora-Huertas H Fessi A Elaissari 2010 Polymer-based nanocapsules for drug delivery Int J Pharm 385 1-2 113 142 10.1016/j.ijpharm.2009.10.018 10.1016/j.ijpharm.2009.10.018 1:CAS:528:DC%2BD1MXhs1Sls7bJ
18. MS Muthu SS Feng 2009 Pharmaceutical stability aspects of nanomedicines Nanomedicine (Lond) 4 8 857 860 10.2217/nnm.09.75 10.2217/nnm.09.75 1:CAS:528:DC%2BD1MXhsFWlsbvF
19. JK Oh 2011 Polylactide (PLA)-based amphiphilic block copolymers: synthesis, self-assembly, and biomedical applications Soft Matter 7 11 5096 5108 10.1039/c0sm01539c 10.1039/c0sm01539c 1:CAS:528:DC%2BC3MXmsVCqsrw%3D
20. M Polakovic T Gorner R Gref E Dellacherie 1999 Lidocaine loaded biodegradable nanospheres II. Modelling of drug release J Control Release 60 2-3 169 177 10.1016/s0168-3659(99)00012-7 10.1016/S0168-3659(99)00012-7 1:CAS:528:DyaK1MXks1Cqu7k%3D (Pubitemid 29335943)
21. A Prokop JM Davidson 2008 Nanovehicular intracellular delivery systems J Pharm Sci 97 9 3518 3590 10.1002/jps.21270 10.1002/jps.21270 1:CAS:528:DC%2BD1cXhtVylt7bN
22. K Riehemann SW Schneider TA Luger B Godin M Ferrari H Fuchs 2009 Nanomedicine-challenge and perspectives Angew Chem Int Edn 48 5 872 897 10.1002/anie.200802585 10.1002/anie.200802585 1:CAS:528:DC%2BD1MXhs1yhtbg%3D
23. M Rizzardini M Zappone P Villa P Gnocchi M Sironi L Diomede C Meazza M Monshouwer L Cantoni 1998 Kupffer cell depletion partially prevents hepatic heme oxygenase 1 messenger RNA accumulation in systemic inflammation in mice: role of interleukin 1beta Hepatology 27 3 703 710 10.1002/hep.510270311 10.1002/hep.510270311 1:CAS:528:DyaK1cXhslGiu7Y%3D (Pubitemid 28103546)
24. P Ruenraroengsak JM Cook AT Florence 2010 Nanosystem drug targeting: facing up to complex realities J Control Release 141 3 265 276 10.1016/j.jconrel.2009.10.032 10.1016/j.jconrel.2009.10.032 1:CAS:528: DC%2BC3cXht1Kls74%3D
25. MW Squire BJ Ludwig JR Thompson J Jagodzinski D Hall D Andes 2008 Premixed antibiotic bone cement-an in vitro comparison of antimicrobial efficacy J Arthroplast 23 6 110 114 10.1016/j.arth.2008.03.014 10.1016/j.arth.2008.03. 014
26. F von Burkersroda L Schedl A Gopferich 2002 Why degradable polymers undergo surface erosion or bulk erosion Biomaterials 23 21 4221 4231 10.1016/S0142-9612(02)00170-9 (Pubitemid 34814991)
27. KY Win SS Feng 2005 Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs Biomaterials 26 15 2713 2722 10.1016/j.biomaterials.2004.07.050 10.1016/j.biomaterials.2004.07.050 1:CAS:528:DC%2BD2cXhtVChsrvP (Pubitemid 39600724)
28. YC Yu G Storti M Morbidelli 2009 Ring-opening polymerization of l,l-lactide: kinetic and modeling study Macromolecules 42 21 8187 8197 10.1021/ma901359x 10.1021/ma901359x 1:CAS:528:DC%2BD1MXht1Crs7%2FN